Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults

NCT00327678 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1080

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Lymphocytic

Interventions

DRUG: Rituximab
DRUG: Imatinib Mesylate

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]